OASMIA PHARMACEUTICAL AB's ticker is OASMY and the CUSIP is 67421W109. A total of 4 filers reported holding OASMIA PHARMACEUTICAL AB in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $17,000 | -15.0% | 19,000 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $20,000 | 0.0% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | -69.7% | 19,000 | -45.8% | 0.00% | -75.0% |
| Q1 2017 | $66,000 | -96.7% | 35,054 | -92.7% | 0.00% | -96.0% |
| Q1 2016 | $2,021,000 | -15.8% | 477,836 | -27.9% | 0.10% | -23.5% |
| Q4 2015 | $2,401,000 | – | 663,138 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN STANLEY | 1 | $0 | 0.00% |
| Citadel Advisors | 16,734 | $22,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 18,439 | $24,000 | 0.00% |
| UBS Group AG | 2,573 | $3,000 | 0.00% |